| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379496A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379494A1 Fused bicyclic or tricyclic amino acids |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379492A1 Inhibitor of monoamine uptake |
| 01/14/2004 | EP1379337A1 Generation of pharmaceutical agent particles using focused acoustic energy |
| 01/14/2004 | EP1379306A1 Device for artificial respiration |
| 01/14/2004 | EP1379279A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | EP1379261A2 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 01/14/2004 | EP1379259A1 Methods of treating syndrome x with aliphatic polyamines |
| 01/14/2004 | EP1379258A1 Low salt forms of polyallylamine |
| 01/14/2004 | EP1379257A2 Prodrugs of anticancer agents employing substituted aromatic acids |
| 01/14/2004 | EP1379256A1 Method for the prevention of tissue elastic fiber injury |
| 01/14/2004 | EP1379255A2 Substituted tetracycline compounds as antifungal agents |
| 01/14/2004 | EP1379254A1 Use of bile acid or bile salt fatty acid conjugates |
| 01/14/2004 | EP1379253A1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 01/14/2004 | EP1379252A2 Nociceptin analogs |
| 01/14/2004 | EP1379251A1 Inhibitors of akt activity |
| 01/14/2004 | EP1379250A2 A method of treating cancer |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379248A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors |
| 01/14/2004 | EP1379247A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379245A1 1, 4, 5, 6-tetrahydropyrazolo- 3, 4-c]-pyrid in-7-ones as factor xa inhibitors |
| 01/14/2004 | EP1379243A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 01/14/2004 | EP1379242A1 Method for treatment of cancer and compositions for use therein |
| 01/14/2004 | EP1379241A1 Compounds and methods |
| 01/14/2004 | EP1379240A1 Compounds and methods |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1379238A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| 01/14/2004 | EP1379237A2 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379236A1 Treatment of tics, tremors and related disorders |
| 01/14/2004 | EP1379235A2 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 01/14/2004 | EP1379233A1 Use of a substantially cell membrane impermeable compound for treating arthritis |
| 01/14/2004 | EP1379232A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
| 01/14/2004 | EP1379231A2 Pharmacologically active strong acid solutions |
| 01/14/2004 | EP1379230A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 01/14/2004 | EP1379229A2 A jasmonate pharmaceutical composition for treatment of cancer |
| 01/14/2004 | EP1379228A1 (z)-styrylbenzylsulfones and pharmaceutical uses thereof |
| 01/14/2004 | EP1379227A1 Microemulsions as precursors to solid nanoparticles |
| 01/14/2004 | EP1379226A2 Animal model for evaluating analgesics |
| 01/14/2004 | EP1379225A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 01/14/2004 | EP1379223A1 Dental formulation |
| 01/14/2004 | EP1379221A2 Pharmaceutical product with reticulated crystalline microstructure |
| 01/14/2004 | EP1379220A2 Inhalation capsules |
| 01/14/2004 | EP1379207A1 Composition for freshening nostrils and sinus cavities |
| 01/14/2004 | EP1379203A1 Condom with an erectogenic composition |
| 01/14/2004 | EP1379146A1 Preparation for the prevention and/or treatment of altered bone metabolism |
| 01/14/2004 | EP1379138A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 01/14/2004 | EP1379135A1 Formulations comprising entrapped active ingredients and uses thereof |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | EP1379130A2 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease |
| 01/14/2004 | EP1341535A4 Skin whiteners containing hydroxytetronic acid |
| 01/14/2004 | EP1324663A4 Probes for targeting of cell density-indicating compounds |
| 01/14/2004 | EP1272189A4 Inhibition of cyclooxygenase-2 activity |
| 01/14/2004 | EP1265882B1 Method for the preparation of citalopram |
| 01/14/2004 | EP1255745B1 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii |
| 01/14/2004 | EP1227811B1 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 01/14/2004 | EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 01/14/2004 | EP1212292B1 (-)-verbenone derivatives |
| 01/14/2004 | EP1189900B1 Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
| 01/14/2004 | EP1150683B9 Utilization of dienogest in high doses |
| 01/14/2004 | EP1115404B1 Use of prostanoid antagonists for the treatment of primary headache disorders |
| 01/14/2004 | EP1112265B1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/14/2004 | EP1095018B1 Aminoiminoquinone and aminoquinone alkaloid compounds as caspase inhibitors |
| 01/14/2004 | EP1082117B1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 01/14/2004 | EP1056448B1 Pharmaceutical combinations containing tramadol |
| 01/14/2004 | EP1027050B1 1,3-thiazoles as adenosine a3 receptor antagonists for the treatment of allergy, asthma and diabetes |
| 01/14/2004 | EP1019385B1 Aminoaryl oxazolidinone n-oxides |
| 01/14/2004 | EP1019059A4 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 01/14/2004 | EP1014989B1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 01/14/2004 | EP1014965B1 Dietary compositions for enhancing metabolism and alleviating oxidative stress |
| 01/14/2004 | EP1011678A4 Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| 01/14/2004 | EP1009394B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 01/14/2004 | EP0939644B1 Enhanced stimulation of erythropoiesis |
| 01/14/2004 | EP0938321B1 Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv |
| 01/14/2004 | EP0934074B1 Use of ginkgo biloba flavonoidic extract comprising up to 1% of terpenes, associated with ceramides, for oral hygiene and compositions containing such extract |
| 01/14/2004 | EP0900088B1 Inclusion complexes of aryl-heterocyclic salts |
| 01/14/2004 | EP0832091B1 C-4' modified adenosine kinase inhibitors |
| 01/14/2004 | CN2598554Y Filled strength scar plaster |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468296A Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 01/14/2004 | CN1468262A Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 01/14/2004 | CN1468259A Immunotherapy for chronic myelocytic leukemia |
| 01/14/2004 | CN1468254A Novel polymorphic form of 17- beta -(n-ter.butyl carbamoyl)-4-aza-5- alpha -androst-1-en-3-one and a process for preparing it |
| 01/14/2004 | CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/14/2004 | CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/14/2004 | CN1468249A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/14/2004 | CN1468247A Ethers of 7-desmethylrapamycin |
| 01/14/2004 | CN1468246A Hydroxyesters of 7-desmethylrapamycin |
| 01/14/2004 | CN1468245A New process for the production of oxabispidines |
| 01/14/2004 | CN1468244A New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 01/14/2004 | CN1468243A Polymorphs of an epothilone analog |
| 01/14/2004 | CN1468242A Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 01/14/2004 | CN1468241A Heterocyclic compounds as ligands of the gabaa receptor |
| 01/14/2004 | CN1468240A Derivatives of variolin b |